HEALTHCARE / SERVICE 05

Capital Allocation Framework for Dental Practices

We build a capital allocation framework that balances debt service, owner distributions, equipment replacement, and hygiene capacity expansion using production per provider, collection rate, and fee schedule realization as the criteria for each decision.

Request a 15-Minute Call

No cost. 15 minutes. No obligation.

We will respond within one business day.

We build a capital allocation framework that balances debt service, owner distributions, equipment replacement, and hygiene capacity expansion using production per provider, collection rate, and fee schedule realization as the criteria for each decision.

The capital allocation framework problem in dental practices

Dental practice owners make capital decisions in isolation: pulling distributions when cash is high, financing new equipment on impulse, or deferring hygiene chair additions because the margin feels tight. Without a deliberate framework, practices overinvest in cosmetic upgrades while hygiene utilization sits at 60 percent, or they underdistribute and accumulate idle cash that should have been reinvested to expand provider capacity. The result is suboptimal compounding: growth stalls because hygiene capacity was never added, or tax efficiency suffers because distributions were taken at the wrong time relative to pass-through income. When buyers perform diligence, they see erratic reinvestment patterns and question whether the practice can sustain production per provider if the owner exits.

Where value leaks

  • Distributions taken in high-production months reduce cash available to fund hygiene chair expansion or associate recruitment, constraining future production per provider.
  • Equipment financing decisions made without modeling impact on overhead as percent of revenue, leading to lease payments that erode margin below DSO benchmarks.
  • Idle cash sitting in operating accounts instead of being allocated to fee schedule optimization initiatives or associate compensation structures that improve collection rate.
  • Owner compensation not calibrated for pass-through taxation, resulting in excess distributions that trigger payroll tax inefficiency and leave insufficient capital for clinical SOP documentation or patient base transferability investments.
  • Deferred maintenance or technology upgrades that eventually require lumpy capital outlays, disrupting cash flow and forcing suboptimal financing at the wrong point in the practice lifecycle.
  • Hygiene utilization remains low because capital was never allocated to adding capacity, leaving production per hygienist below the threshold that justifies additional chair investment.

What we build for dental practices

Capital allocation decision tree that prioritizes debt service, owner distributions, hygiene capacity expansion, and associate recruitment based on current production per provider and collection rate thresholds.

Distribution policy tied to fee schedule realization and overhead as percent of revenue, ensuring owner comp is tax-efficient and leaves sufficient capital for reinvestment in patient base transferability.

Equipment and technology investment criteria calibrated to impact on production per provider and collection rate, with financing structure modeled against DSO margin benchmarks.

Hygiene utilization expansion roadmap that defines the production per hygienist threshold and collection rate stability required before adding chairs or hiring additional hygienists.

Quarterly capital allocation scorecard that shows actual spend against framework priorities, with variance explanations tied to KPIs like fee schedule realization and overhead ratio.

Exit readiness capital plan that allocates dollars to clinical SOP documentation, associate compensation realignment, and production reporting cleanup in the 18 to 24 months before a sale process.

KPIs this moves for dental practices

  • Production per provider: Framework directs capital toward associate recruitment and hygiene capacity only when current providers exceed production thresholds, preventing premature overhead expansion.
  • Collection rate: Allocation priority given to billing system upgrades, insurance verification processes, and fee schedule optimization before discretionary distributions or cosmetic facility upgrades.
  • Hygiene utilization: Capital earmarked for hygiene chair additions and hygienist hiring only when utilization exceeds 75 percent and collection rate stability is documented.
  • Fee schedule realization: Reinvestment in payer contract renegotiation and fee analysis tools funded before owner distributions, ensuring margin expansion supports future capital needs.
  • Overhead as percent of revenue: Equipment lease payments and facility upgrades modeled to keep overhead within DSO benchmarks (typically 60 to 65 percent for solo practices), preserving margin for distributions and debt service.
  • Buyer and exit lens for dental practices

    DSO acquirers and private equity platforms run diligence on capital allocation discipline because it signals whether the practice can sustain production per provider and hygiene utilization post-transaction. A documented framework that shows deliberate reinvestment in associate compensation, clinical SOPs, and patient base transferability supports the 5 to 8x Adjusted EBITDA range for solo or add-on sales, while practices that allocated capital erratically or prioritized distributions over hygiene capacity expansion face multiple compression. Regional platforms and larger DSOs paying 9 to 11x expect to see a capital plan that has already funded the infrastructure for transferable production and collection systems.

    FAQ

    Capital Allocation Framework questions for dental practices

    How do we decide when to take distributions versus reinvesting in hygiene capacity?

    We build a decision tree that compares current hygiene utilization and production per hygienist against thresholds (typically 75 percent utilization and $750 to $850 per day per hygienist). If utilization is below threshold and collection rate is stable, capital is allocated to adding hygiene capacity before distributions are increased. If utilization is at threshold but fee schedule realization is low, we prioritize payer contract renegotiation or fee optimization before expanding chairs. Distributions are sized to meet owner tax obligations and target comp, with excess cash allocated according to the framework.

    What if we need to finance new equipment but our overhead is already above DSO benchmarks?

    We model the lease payment against current overhead as percent of revenue and production per provider to determine whether the equipment will improve collection rate or production enough to offset the incremental cost. If overhead is already at 65 percent and the equipment does not directly enhance production per provider or fee schedule realization, we defer the purchase or explore used equipment options. If the equipment is critical for clinical standards or patient base transferability, we identify offsetting cost reductions in other overhead categories before proceeding with financing.

    How do we know if we are overinvesting or underinvesting in the practice?

    Overinvestment shows up as declining production per provider despite capital spend, or hygiene utilization remaining low after adding chairs. Underinvestment appears as stagnant collection rate, deferred technology that buyers flag in diligence, or owner-dependent production that cannot be transferred because associate compensation was never calibrated. We compare your capital allocation pattern against your KPIs (production per provider, collection rate, hygiene utilization, fee schedule realization) and DSO margin benchmarks to identify whether each dollar is compounding or leaking.

    Does the framework change if we are planning to sell in the next 18 to 24 months?

    Yes. In an exit readiness window, the framework shifts capital toward investments that directly enhance transferability and clean reporting: clinical SOP documentation, associate compensation realignment to reduce owner dependency, production and collection system upgrades, and fee schedule optimization. Discretionary equipment purchases and facility cosmetic upgrades are deferred unless they materially improve production per provider or support the 5 to 8x Adjusted EBITDA range for solo or add-on sales. We also model distributions to avoid excess cash drag while ensuring the practice has sufficient working capital for a clean transition.

    More for Dental Practices

    More healthcare verticals

    Start with where you actually stand.

    The Keystone Value Creation Assessment audits your last 12 to 36 months and gives you a written summary whether you engage us or not. If there is not a clear opportunity to create value, we will tell you directly.

    CallBook a CallEmail